Citations

Showing 10 of 108162 citations.

ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components
Shinohara, Mitsuru , Yamazaki, Akari, Ren, Yingxue , Asmann, Yan W. , Kanekiyo, Takahisa , Bu, Guojun , Bu, Guojun , Yamazaki, Yu

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | October 31, 2019 | Volume: 40 | Issue: 1 | Pages: 128-144

10.1161/atvbaha.119.313169 | PMID 31665905 Get It

Objective: The ε4 allele of the APOE gene ( APOE4 ) is the strongest genetic risk factor for Alzheimer disease when compared with the common ε3 allele. Although there has been significant progress in understanding how apoE4 (apolipoprotein E4) drives amyloid pathology, its effects on amyloid-independent pathways, in particular cerebrovascular integrity and function, are less clear. Approach and Results: Here, we show that brain pericytes, the mural cells of the capillary walls, differentially modulate endothelial cell phenotype in an apoE isoform-dependent manner. Extracellular matrix protein induction, tube-like structure formation, and barrier formation were lower with endothelial cells cocultured with pericytes isolated from apoE4-targeted replacement (TR) mice compared with those from apoE3-TR mice. Importantly, aged apoE4-targeted replacement mice had decreased extracellular matrix protein expression and increased plasma protein leakages compared with apoE3-TR mice. Conclusions: ApoE4 impairs pericyte-mediated basement membrane formation, potentially contributing to the cerebrovascular effects of apoE4.
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Haak, Andrew J. , Kostallari, Enis , Sicard, Delphine , Ligresti, Giovanni , Choi, Kyoung Moo , Caporarello, Nunzia , Jones, Dakota L. , Tan, Qi , Meridew, Jeffrey A., Espinosa, Ana M. Diaz , Aravamudhan, Aja, Maiers, Jessica L. , Britt, Rodney D. , Roden, Anja C. , Prakash, Y. S. , Nouraie, Mehdi , Li, Xiaoyun , Lagares, David , Tager, Andrew M. , Varelas, Xaralabos , Shah, Vijay H. , Tschumperlin, Daniel J. , Zhang, Yingze , Meridew, Jeffrey, Diaz Espinosa, Ana M , Pabelick, Christina M , Prakash, Y S , Nouraie, Seyed Mehdi , Li, Xiaoyun , Zhang, Yingze , Lagares, David , Varelas, Xaralabos , Shah, Vijay H , Tschumperlin, Daniel J , Kostallari, Enis , Caporarello, Nunzia , Ligresti, Giovanni , Pabelick, Christina M. , Kass, Daniel J.

Mayo Clinic

Science Translational Medicine | October 30, 2019 | Volume: 11 | Issue: 516 | Pages: No page available

10.1126/scitranslmed.aau6296 | PMID 31666402 Get It

Pharmacologic stimulation of a G protein–coupled receptor preferentially expressed on fibroblasts reverses experimental lung and liver fibrosis.
Disease Severity and Cost in Adhesive Small Bowel Obstruction
Finnesgard, Eric J. , Shariq, Omair A. , Knight, Ariel W. , Stephens, Daniel J. , Aho, Johnathon M. , Kim, Brian D. , Schiller, Henry J., Zielinski, Martin D. , Stephens, Daniel , Knight, Ariel, Hernandez, Matthew C. , Stephens, Daniel, Stephens, Daniel

Mayo Clinic

World Journal of Surgery | October 30, 2019 | Volume: 43 | Issue: 12 | Pages: 3027-3034

10.1007/s00268-019-05148-y | PMID 31555867 Get It

AbstractBackgroundAdhesive small bowel obstruction (ASBO) severity has been associated with important clinical outcomes. However, the impact of ASBO severity on hospitalization cost is unknown. The American Association for the Surgery of Trauma (AAST) developed an Emergency General Surgery (EGS) disease severity grading system for ASBO. We stratified patients’ ASBO severity and captured hospitalization costs hypothesizing that increased disease severity would correlate with greater costs.MethodsThis was a single‐center study of hospitalized adult patients with SBO during 2015–2017. Clinical data and estimated total cost (direct + indirect) were abstracted. AAST EGS grades (I–IV) stratified disease severity. Costs were normalized to the median grade I cost. Univariate and multivariate analyses evaluated the relationship between normalized cost and AAST EGS grade, length of hospital and ICU stay, operative time, and Charlson comorbidity index.ResultsThere were 214 patients; 119 (56%) were female. AAST EGS grades included: I (62%, n = 132), II (23%, n = 49), III (7%, n = 16), and IV (8%, n = 17). Relative to grade I, median normalized cost increased by 1.4‐fold for grade II, 1.6‐fold for grade III, and 4.3‐fold for grade IV disease. No considerable differences in patient comorbidity between grades were observed. Pair‐wise comparisons demonstrated that grade I disease cost less than higher grades (corrected p < 0.001). Non‐operative management was associated with lower normalized cost compared to operative management (1.1 vs. 4.5, p < 0.0001). In patients who failed non‐operative management, normalized cost was increased 7.2‐fold. Collectively, the AAST EGS grade correlated well with cost (Spearman's p = 0.7, p < 0.0001). After adjustment for covariates, AAST EGS grade maintained a persistent relationship with cost.ConclusionIncreasing ASBO severity is independently associated with greater costs. Efforts to identify and mitigate costs associated with this burdensome disease are warranted.Level of evidenceIII, economic/decision.
Visuomotor Ankle Training on a Stiffness-Controlled Robotic Platform Improves Ankle Motor Control and Lower Extremity Function in Chronic Stroke Survivors
Hennington, Lindsey, Eikenberry, Megan , Kinney, Carolyn L. , Lee, Hyunglae , Kinney, Carolyn , Nalam, Varun

Mayo Clinic

IEEE Transactions on Medical Robotics and Bionics | October 30, 2019 | Volume: 1 | Issue: 4 | Pages: 237-246

10.1109/tmrb.2019.2950119 Get It

National trends in coronary intensive care unit admissions, resource utilization, and outcomes
Woolridge, Sarah, Alemayehu, Wendimagegn , Kaul, Padma , Lawler, Patrick R. , Lemay, Michel, Wong, Graham C., Lawler, Patrick , Fordyce, Christopher B. , Lemay, Michel, Jentzer, Jacob C. , Goldfarb, Michael , Armstrong, Paul W. , Diepen, Sean van

Mayo Clinic

European Heart Journal. Acute Cardiovascular Care | October 30, 2019 | Volume: 9 | Issue: 8 | Pages: 923-930

10.1177/2048872619883400 | PMID 31663772 Get It

Background: Emerging evidence suggests that coronary intensive care units are evolving into intensive care environments with an increasing burden of non-cardiovascular illness, but previous studies have been limited to older populations or single center experiences. Methods: Canadian national health-care data was used to identify all patients ≥18 years admitted to dedicated coronary intensive care units (2005–2015) and admissions were categorized as primary cardiac or non-cardiac. The outcomes of interest included longitudinal trends in admission diagnoses, critical care therapies, and all-cause in-hospital mortality. Results: Among the 373,992 patients admitted to a coronary intensive care unit, minimal changes in the proportion of patients admitted with a primary cardiac (88.2% to 86.9%; p&lt;0.001) and non-cardiac diagnoses (11.8% to 13.1%; p&lt;0.001) were observed. Among cardiac admissions, a temporal increase in the proportion of ST-segment elevation myocardial infarction (19.4% to 24.1%, p&lt;0.001), non-ST-segment elevation myocardial infarction (14.6% to 16.2%, p&lt;0.001), heart failure (7.3% to 8.4%, p&lt;0.001), shock (4.9% to 5.7%, p&lt;0.001), and decline in unstable angina (4.9% to 4.0%, p&lt;0.001) and stable coronary diseases (21.3% to 12.4%, p&lt;0.001) was observed. The proportion of patients requiring critical care therapies (57.8% to 63.5%, p&lt;0.001) including mechanical ventilation (9.6% to 13.1%, p&lt;0.001) increased. In-hospital mortality rates for patients with primary cardiac (4.9% to 4.4%; adjusted odds ratio 0.71, 95% confidence interval 0.63–0.79) and non-cardiac (17.8% to 16.1%; adjusted odds ratio 0.84, 0.73–0.97) declined; results were consistent when stratified by academic vs community hospital, and by the presence of on-site percutaneous coronary intervention. Conclusion: In a national dataset we observed a changing case-mix among patients admitted to a coronary intensive care unit, though the proportion of patients with a primary cardiac diagnosis remained stable. There was an increase in clinical acuity highlighted by critical care therapies, but in-hospital mortality rates for both primary cardiac and non-cardiac conditions declined across all hospitals. Our findings confirm the changing coronary intensive care unit case-mix and have implications for future coronary intensive care unit training and staffing.
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
Nijman, Thomas, Taylor, Angela E. , Ronchi, Cristina L. , Schreiner, Jochen, Asia, Miriam, Riester, Anna , Perotti, Paola, Quinkler, Marcus , Bugalho, Maria João , Kaštelan, Darko , Dennedy, Michael Conall , Ambroziak, Urszula , Vassiliadi, Dimitra A. , Beuschlein, Felix , Deeks, Jonathan J , Biehl, Michael , Arlt, Wiebke , Arlt, Wiebke , Quinkler, Marcus , Dennedy, M Conall , Beuschlein, Felix , Ambroziak, Urszula , Taylor, Angela E , Kastelan, Darko , Ronchi, Cristina L , Chortis, Vasileios , Bancos, Irina , Nijman, Thomas, Gilligan, Lorna C , O'Reilly, Michael W , Libé, Rossella , Canu, Letizia , Paiva, Isabel , Sherlock, Mark , Bertherat, Jérôme , Faßnacht, Martin

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 30, 2019 | Volume: 105 | Issue: 3 | Pages: e307-e318

10.1210/clinem/dgz141 | PMID 31665449 Get It

Abstract Context Urine steroid metabolomics, combining mass spectrometry-based steroid profiling and machine learning, has been described as a novel diagnostic tool for detection of adrenocortical carcinoma (ACC). Objective, Design, Setting This proof-of-concept study evaluated the performance of urine steroid metabolomics as a tool for postoperative recurrence detection after microscopically complete (R0) resection of ACC. Patients and Methods 135 patients from 14 clinical centers provided postoperative urine samples, which were analyzed by gas chromatography–mass spectrometry. We assessed the utility of these urine steroid profiles in detecting ACC recurrence, either when interpreted by expert clinicians or when analyzed by random forest, a machine learning-based classifier. Radiological recurrence detection served as the reference standard. Results Imaging detected recurrent disease in 42 of 135 patients; 32 had provided pre- and post-recurrence urine samples. 39 patients remained disease-free for ≥3 years. The urine “steroid fingerprint” at recurrence resembled that observed before R0 resection in the majority of cases. Review of longitudinally collected urine steroid profiles by 3 blinded experts detected recurrence by the time of radiological diagnosis in 50% to 72% of cases, improving to 69% to 92%, if a preoperative urine steroid result was available. Recurrence detection by steroid profiling preceded detection by imaging by more than 2 months in 22% to 39% of patients. Specificities varied considerably, ranging from 61% to 97%. The computational classifier detected ACC recurrence with superior accuracy (sensitivity = specificity = 81%). Conclusion Urine steroid metabolomics is a promising tool for postoperative recurrence detection in ACC; availability of a preoperative urine considerably improves the ability to detect ACC recurrence.
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity
Kadouh, Hoda C., Chedid, Victor , Halawi, Houssam , Burton, Duane D. , Clark, Matthew M. , Khemani, Disha, Camilleri, Michael , Kadouh, Hoda, Chedid, Victor G , Vella, Adrian , Acosta, Andrés

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 30, 2019 | Volume: 105 | Issue: 5 | Pages: 1552-1563

10.1210/clinem/dgz140 | PMID 31665455 Get It

Abstract Purpose Obesity is associated with alterations in appetite, gastrointestinal hormone levels and excessive fat mass. We previously published a double-blind, placebo-controlled, randomized, 16-week trial on effects of once-daily glucagon-like peptide-1 (GLP-1) analog, liraglutide on weight, satiation, and gastric functions in obese volunteers. The aim of this substudy is to compare to placebo the effects of liraglutide on appetite, taste preference, regional body fat stores, and anthropometric measurements. Methods Forty obese adults received standard instruction for weight management, monthly behavioral intervention utilizing motivational interviews, and 16-week treatment of once-daily liraglutide (escalated to 3 mg SQ daily). At baseline and 16 weeks, the following were measured: appetite and taste preferences rated every 30 min for 5 h after ingesting 300 mL Ensure®; maximal tolerated volume (MTV) with a nutrient drink test; fasting and postprandial bioactive GLP-1 (7–36) and peptide YY (PYY) levels; total and regional body fat with dual-energy X-ray absorptiometry, and waist and hip circumference. Results Thirty-five participants (17 liraglutide; 18 placebo) completed the trial. Compared to placebo group, liraglutide group had significant reductions in MTV; prospective food consumption score; desire to eat something sweet, salty, savory or fatty; and an increase in perceived fullness. Postprandial plasma levels of GLP-1 decreased and PYY levels increased with liraglutide relative to baseline. Significant reductions in total body, trunk, and upper and lower body fat without reduction in lean body mass were observed. Conclusion Liraglutide 3 mg SQ modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity without reduction in lean body mass.
The outcomes ofClostridioides difficileinfection in patients with diverticular disease: a nationwide analysis
Abdalla, Abubaker , Narala, Sai B., Abdallah, Mohamed A., Doshi, Rajkumar , Gullapalli, Nageshwara , Abdalla, Abubaker O , Doshi, Rajkumar P , Abdallah, Mohamed A.

Mayo Clinic

Scandinavian Journal of Gastroenterology | October 30, 2019 | Volume: 54 | Issue: 11 | Pages: 1353-1356

10.1080/00365521.2019.1683223 | PMID 31663792 Get It

Performance and Return to Sport After Anterior Cruciate Ligament Reconstruction in Professional Baseball Players
Chalmers, Peter N. , D’Angelo, John , Ma, Kevin , Dahm, Diane L., Erickson, Brandon J. , Romeo, Anthony A. , Ahmad, Christopher S.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 30, 2019 | Volume: 7 | Issue: 10 | Pages: No page available

10.1177/2325967119878431 | PMID 31696134 Get It

Background: Anterior cruciate ligament reconstruction (ACLR) is the gold standard treatment for ACL tears to allow baseball players to return to sport (RTS). The optimal graft type and femoral tunnel drilling technique are currently unknown. Hypothesis: There is a high rate of RTS in professional baseball players after ACLR, with no significant difference in RTS rates or performance between cases and controls or between graft types or femoral drilling techniques. Study Design: Cohort study; Level of evidence, 3. Methods: All professional baseball players who underwent ACLR between 2010 and 2015 were included. Demographic and performance data (pre- and postoperative) for each player were recorded. Performance metrics were then compared between cases and matched controls. Results: A total of 124 players (mean age, 23.7 ± 4.1 years; 83% minor league players) underwent ACLR. Of these, 80% returned to sport (73% to the same or higher level) at a mean 310 ± 109 days overall and 333 ± 126 days at the same or higher level. The most common graft type was an ipsilateral bone–patellar tendon–bone (BTB) autograft (n = 87; 70%). A total of 91 players underwent concomitant meniscal debridement or repair. No significant difference in any of the primary performance metrics existed from before to after ACLR. Compared with matched controls, no significant difference existed in RTS rates or any performance metrics after ACLR. No significant difference existed in RTS rates or primary performance outcome measures between graft types or femoral drilling techniques. Conclusion: The RTS rate for professional baseball players after ACLR was 80%. No significant difference in performance metrics existed between BTB and hamstring autografts or between femoral drilling techniques. Furthermore, no significant difference in performance or RTS rates existed between cases and matched controls. Femoral drilling technique and graft type did not affect performance and RTS rates in professional baseball players after ACLR.
Artificial Intelligence in Radiology: A Call for Thoughtful Application
Driver, Christine , Bartholmai, Brian J. , Greenberg, Alexandra J. , Driver, C Noelle, Bowles, Bradley S, Bartholmai, Brian J , Driver, C. Noelle, Bowles, Bradley

Mayo Clinic

Clinical and Translational Science | October 30, 2019 | Volume: 13 | Issue: 2 | Pages: 216-218

10.1111/cts.12704 | PMID 31664767 Get It